Cariprazine
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 581 publications
Dopamine Receptor Modulation in Co-Occurring Disorders: Potential of Cariprazine and D3 Receptor Activity.
Journal: Journal of dual diagnosis
Published: June 11, 2026
Marked Improvement of Chronic Motor and Phonic Tics With Cariprazine in an Adult With Tourette Syndrome With Comorbid Bipolar Disorder: A Case Report.
Journal: Cureus
Published: May 17, 2026
Improvement in Antipsychotic-Related Sexual Dysfunction After Switching to Cariprazine: A Prospective Real-World Study.
Journal: Journal of clinical medicine
Published: March 05, 2026
Efficacy and Safety of Lumateperone and Other Atypical Antipsychotics Approved as Adjunctive Treatment for Major Depressive Disorder in the United States: A Network Meta-Analysis.
Journal: Advances in therapy
Published: February 27, 2026
Stability indicating HPLC method development and validation for the determination of organic impurities of cariprazine hydrochloride, their characterization by LC-MS and NMR techniques.
Journal: BMC chemistry
Published: February 25, 2026
Intranasal Chitosan Nanoparticles for Direct Nose-to-Brain Delivery of Cariprazine: A Noninvasive Strategy for Targeted CNS Therapy.
Journal: ACS chemical neuroscience
Published: February 23, 2026
Transferrin-Functionalized Chitosan Nanoparticles Enable Intranasal Brain Delivery of Cariprazine with Enhanced Neuropharmacological Efficacy.
Journal: ACS chemical neuroscience
Published: February 05, 2026
Differential effects of cariprazine, LY379268 and donepezil on EEG oscillations and auditory steady-state response in MK-801-treated rats: relevance for schizophrenia drug development.
Journal: Neuropharmacology
Published: January 28, 2026
Lumateperone (Caplyta) for adjunctive treatment of depression.
Journal: The Medical letter on drugs and therapeutics
Published: January 23, 2026
Last Updated: 06/30/2026